SOPHSOPHiA GENETICS S.A.

SOPH Stock Price, Valuation & Chart | SOPHiA GENETICS S.A.

$8.280-0.14 (-1.72%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Healthcare Information Services SOPH intrinsic value SOPH calculated fair value vs price

Overview Financials Dividends Ratios

SOPH Historical price chart

SOPH Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization694.65M

PE Ratio-7.46

EPS-1.11

Trading Volume809.62K

Today's High/Low8.47/7.82

Dividend Yield0.00

52 Week High/Low8.98/3.1

Shares Outstanding83.90M

SOPH Financial Statement

SOPH Analyst ratings

SOPH Analysis & performance metrics

SOPH Company profile

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and…

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS…

SOPH Management team

Name

Position

Ross Jordan Muken B.Sc.

President

Philippe Menu M.B.A., M.D., Ph.D.

Executive Vice President, Chief Medical Officer & Chief Product Officer

Kevin Puylaert

Vice President & MD of EMEA

Jurgi Camblong M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Zhenyu Xu Ph.D.

Executive Vice President & Chief Scientific Officer

Kellen Sanger

Head of Strategy and Investor Relations

Daan van Well L.L.M., M.B.A.

Executive Vice President, Chief Legal & Regulatory Officer

George A. Cardoza M.B.A.CFO

Executive Vice President & Chief Financial Officer

Name

Position

Ross Jordan Muken B.Sc.

President

Philippe Menu M.B.A., M.D., Ph.D.

Executive Vice President, Chief Medical Officer & Chief Product Officer

Kevin Puylaert

Vice President & MD of EMEA

Jurgi Camblong M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Zhenyu Xu Ph.D.

Executive Vice President & Chief Scientific Officer

Kellen Sanger

Head of Strategy and Investor Relations

Daan van Well L.L.M., M.B.A.

Executive Vice President, Chief Legal & Regulatory Officer

George A. Cardoza M.B.A.CFO

Executive Vice President & Chief Financial Officer

Management Team

Ross Jordan Muken B.Sc.

President

Philippe Menu M.B.A., M.D., Ph.D.

Executive Vice President, Chief Medical Officer & Chief Product Officer

Kevin Puylaert

Vice President & MD of EMEA

Jurgi Camblong M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Zhenyu Xu Ph.D.

Executive Vice President & Chief Scientific Officer

Kellen Sanger

Head of Strategy and Investor Relations

Daan van Well L.L.M., M.B.A.

Executive Vice President, Chief Legal & Regulatory Officer

George A. Cardoza M.B.A.CFO

Executive Vice President & Chief Financial Officer

Management

Ross Jordan Muken B.Sc.

President

Philippe Menu M.B.A., M.D., Ph.D.

Executive Vice President, Chief Medical Officer & Chief Product Officer

Kevin Puylaert

Vice President & MD of EMEA

Jurgi Camblong M.B.A., Ph.D.CEO

Co-Founder, Chief Executive Officer & Director

Zhenyu Xu Ph.D.

Executive Vice President & Chief Scientific Officer

Kellen Sanger

Head of Strategy and Investor Relations

Daan van Well L.L.M., M.B.A.

Executive Vice President, Chief Legal & Regulatory Officer

George A. Cardoza M.B.A.CFO

Executive Vice President & Chief Financial Officer

Total 8 executives

SOPH Frequently asked questions

What is SOPHiA GENETICS S.A. (SOPH) Stock Price?

Current stock price of SOPHiA GENETICS S.A. (SOPH) stock is $8.280. The stock price is -1.72% lower in the session. The intraday range can be seen from this page. Volume of SOPHiA GENETICS S.A. (SOPH) stock is 809.62K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the SOPHiA GENETICS S.A. (SOPH) stock price going up or down today?

The stock price of SOPHiA GENETICS S.A. (SOPH) can change with earnings, company news, and overall market sentiment. SOPHiA GENETICS S.A. operates in the Healthcare / Medical - Healthcare Information Services market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the SOPHiA GENETICS S.A. stock expensive at its current price?

Whether SOPHiA GENETICS S.A. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SOPH on this page is -7.46. EPS on this page is -1.11. Compare those figures with peers and growth expectations before deciding if the current SOPHiA GENETICS S.A. price is justified.

How has the stock price of SOPHiA GENETICS S.A. (SOPH) performed historically?

Historical performance for SOPHiA GENETICS S.A. (SOPH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SOPH reacted to past earnings and market events.

Should I buy SOPHiA GENETICS S.A. (SOPH) stock, at this price?

Buying SOPHiA GENETICS S.A. (SOPH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.